Adenovirus as vector for HIV: efficacy and safety issues
Natuk, R.J.; Wade, M.S.; Chengalvala, M.; Murthy, K.K.; Chanda, P.K.; Murthy, S.C.; Bhat, B.M.; Bhat, R.; Dheer, S.K.; Mizutani, S.
Developments in Biological Standardization 84: 153-156
1995
ISSN/ISBN: 0301-5149 PMID: 7796948 Document Number: 446942
Document emailed within 1 workday
Related Documents
Vohora, D. 2007: Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia Current Opinion in Investigational Drugs 8(7): 531-538Chi, I.C.; Petta, C.A.; McPheeters, M. 1995: A review of safety, efficacy, pros and cons, and issues of puerperal tubal sterilization--an update Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 11(3): 187-206
Wang, D.; Liu, M.; Wang, M.; Zhang, Y. 2008: Construction of recombinant adenovirus vector by c-myc silencing Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(8): 969-973
Lü, Y.-J.; Miao, S.-S.; Liu, W.-S.; He, H.-J.; Jia, S.-S.; He, G.-Q.; Xiang, C. 2011: Construction and confirmation of a recombinant adenovirus vector of survivin Zhonghua Zhong Liu Za Zhi 33(1): 13-17
Cheng, X.; Lin, H.; Xue, J.; Zhang, T. 2010: Construction of human GDF-5 on adenovirus vector and its expression in MSCs Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(1): 120-125
Li, J.; Xia, Y.; Jiang, L.; Hu, S.; Xu, H. 1997: Inhibition of vascular smooth muscle cell proliferation by introduction of retinoblastoma gene via a recombinant adenovirus vector Chinese Medical Journal 110(12): 950-954
Chen, Z.; Li, T.; Hu, S.; Wang, G. 2009: Construction of recombinant adenovirus vector containing rat insulin-like growth factor 1 gene and its expression in islet beta-cells Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(5): 1067-1071
Gallichan, W.S.; Johnson, D.C.; Graham, F.L.; Rosenthal, K.L. 1995: Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus Advances in Experimental Medicine and Biology 371b: 1581-1585
Chen, G.; Mou, L.-p.; Yao, J.; You, T.-t.; Shen, X.-y.; Zhu, X.-q.; Qiao, Y.-f.; Lin, M.; Fang, X.-w.; Zou, X.; Lin, L.-x. 2008: Construction of GSK-3beta-targeting RNAi adenovirus vector and the influence of Wnt/beta-catenin pathway in proliferation of human thyrocytes Zhonghua Yi Xue Za Zhi 88(40): 2821-2825
Xue, J.; Peng, J.; Zhang, L.; Liu, S.; Chen, J.; Wang, A.; Yuan, M.; Xu, W.; Lu, S. 2010: Construction of recombinant adenovirus vector pAdxsi-green fluorescent protein-homo sapiens NEL-like 1 and transfected into rat bone marrow mesenchymal stem cells Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(5): 606-612
Timme, T.L.; Hall, S.J.; Barrios, R.; Woo, S.L.; Aguilar-Cordova, E.; Thompson, T.C. 1998: Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice Cancer Gene Therapy 5(2): 74-82
Offenbartl, K. 2008: "From blame and shame to patient safety work in an educational and nourishing environment". Patient safety issues belong on the "workshop floor" Lakartidningen 105(15): 1112
Sato, T.; Kariya, K. 1996: Theoretical prediction of safety and efficacy of drugs--safety Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 108(3): 183-185
Zhu, M.; Dai, Y. 1999: Bio-safety testing for retroviral vector as gene therapy delivery system Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 13(1): 48-50
Friedman, A.J.; Wheeler, J. 1991: Efficacy and safety of ethynodiol diacetate 1 mg with ethynylestradiol 35 ug with an emphasis on contraceptive efficacy a phase iv trial Journal of Reproductive Medicine 36(4 Suppl): 328-333
Aimono, Y.; Kamoshida, T.; Sakamoto, R.; Nemoto, M.; Saito, Y.; Aoyama, Y.; Maruyama, T. 2015: Initial Evaluation of the Efficacy and Safety of Tablets Containing Trifluridine and Tipiracil Hydrochloride--Safety Measures Devised by a Multidisciplinary Team Including a Pharmaceutical Outpatient Clinic Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(7): 817-820
Wang, H.; Baker, V.V. 2000: Synergistic efficacy of adenovirus-mediated bcl-Xs gene therapy and cisplatin in ovarian cancer cell Zhonghua Fu Chan Ke Za Zhi 35(2): 94-97
Koblin, B.A.; Casapia, M.; Morgan, C.; Qin, L.; Wang, Z.M.; Defawe, O.D.; Baden, L.; Goepfert, P.; Tomaras, G.D.; Montefiori, D.C.; McElrath, M.J.; Saavedra, L.; Lau, C.-Y.; Graham, B.S. 2011: Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial PLOS one 6(9): E24517
Rodkvamtook, W.; Prasartvit, A.; Jatisatienr, C.; Jatisatienr, A.; Gaywee, J.; Eamsobhana, P. 2012: Efficacy of plant essential oils for the repellents against chiggers (Leptotrombidium imphalum) vector of scrub typhus Journal of the Medical Association of Thailand 95(Suppl 5): S103-S106
Chaplygina, N.M.; Kalinina, T.I.; Gartel', A.L.; Ponomareva, T.I.; Tiunnikov, G.I. 1981: Virus sequences in the DNA of rat cells transformed by the DNA of monkey adenovirus SA7 and the DNA of human type 6 adenovirus Vestnik Akademii Meditsinskikh Nauk SSSR 2: 64-71